ALPS Medical Breakthroughs ETF Rating $30.93 -0.35 (-1.12%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$30.78 -0.15 (-0.48%) As of 06/13/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.90Holdings in SBIO have an aggregate rating of Moderate Buy based on 790 analyst ratings issued in the past year covering 97 companies (99.9% of the portfolio).SBIO Aggregate Price Target$30.93High Prediction$30.93Average Prediction$30.93Low Prediction$30.93Holdings in SBIO have an aggregate price target of $30.93 and a range of $30.93 to $30.93 covering 97 companies (99.9% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy53 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 97 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.51%VRNAVerona Pharma$92.20-0.3%1.948 of 5 stars3.10$87.44 -5.2%10Trending NewsAnalyst ForecastInsider TradeAnalyst Revision4.28%ALKSAlkermes$29.83-3.1%4.6914 of 5 stars2.77$38.85 30.2%13Insider Trade4.12%AXSMAxsome Therapeutics$104.10-2.0%4.7377 of 5 stars3.06$172.33 65.5%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.41%RYTMRhythm Pharmaceuticals$62.90-0.2%4.1433 of 5 stars3.00$76.62 21.8%13Insider Trade3.35%PTCTPTC Therapeutics$51.26+0.5%3.8423 of 5 stars2.64$63.75 24.4%14Analyst RevisionGap Down3.34%RNAAvidity Biosciences$31.37-2.4%1.9259 of 5 stars3.07$67.33 114.6%15Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionGap Down3.25%ACADACADIA Pharmaceuticals$21.71-0.1%3.2269 of 5 stars2.69$26.79 23.4%16Analyst Revision3.25%AKROAkero Therapeutics$55.62+3.8%3.6067 of 5 stars3.00$82.50 48.3%7Trending NewsInsider TradeGap DownHigh Trading Volume3.15%MRUSMerus$54.61-1.4%3.0613 of 5 stars3.13$85.83 57.2%152.86%ZLABZai Lab$41.00-4.7%1.2697 of 5 stars2.75$47.37 15.5%4Analyst RevisionGap Down2.61%PTGXProtagonist Therapeutics$56.37+0.1%1.9881 of 5 stars3.00$65.44 16.1%9Insider Trade2.49%CRNXCrinetics Pharmaceuticals$31.77-1.2%3.5257 of 5 stars2.91$74.56 134.7%11Positive NewsAnalyst RevisionGap Down2.22%MLTXMoonLake Immunotherapeutics$44.21+0.4%2.0511 of 5 stars3.00$78.71 78.0%8Analyst Revision2.00%BCRXBioCryst Pharmaceuticals$10.37-0.3%4.3375 of 5 stars2.89$16.56 59.6%9Positive NewsAnalyst Revision1.95%XENEXenon Pharmaceuticals$32.76-0.1%3.6625 of 5 stars3.00$54.82 67.3%12Options VolumeAnalyst Revision1.92%MIRMMirum Pharmaceuticals$49.63+1.2%3.2186 of 5 stars3.17$60.73 22.4%12Analyst Revision1.88%VCELVericel$42.67+0.4%2.4725 of 5 stars3.00$61.14 43.3%7Positive NewsGap Down1.80%DNLIDenali Therapeutics$14.55-2.5%4.335 of 5 stars3.06$33.71 131.7%17Positive NewsAnalyst RevisionGap Down1.76%CGONCG Oncology$25.86-2.4%2.4563 of 5 stars3.00$58.22 125.1%11Positive NewsAnalyst RevisionGap Down1.74%GLPGGalapagos$28.76-0.4%0.2648 of 5 stars1.50$25.33 -11.9%81.67%NAMSNewAmsterdam Pharma$20.21-3.9%2.9609 of 5 stars3.00$43.00 112.8%7Positive NewsAnalyst ForecastAnalyst Revision1.67%FOLDAmicus Therapeutics$6.03-2.3%3.9658 of 5 stars2.70$16.22 169.0%101.61%AGIOAgios Pharmaceuticals$34.30-0.6%3.9345 of 5 stars2.71$58.60 70.8%7Positive NewsAnalyst Revision1.49%APGEApogee Therapeutics$44.48+6.3%2.393 of 5 stars3.00$94.60 112.7%5Positive NewsGap DownHigh Trading Volume1.49%IDYAIDEAYA Biosciences$22.18-0.4%3.851 of 5 stars2.93$54.27 144.7%14Analyst RevisionGap Down1.45%TARSTarsus Pharmaceuticals$40.89-0.1%2.1236 of 5 stars3.00$66.67 63.0%71.42%IRONDisc Medicine$53.71+1.9%2.1639 of 5 stars3.09$96.70 80.0%11Analyst ForecastAnalyst RevisionHigh Trading Volume1.40%IMCRImmunocore$34.68-2.7%3.0455 of 5 stars2.55$58.89 69.8%11Positive NewsAnalyst UpgradeAnalyst Revision1.19%GPCRStructure Therapeutics$21.68-2.4%2.427 of 5 stars3.00$76.50 252.9%7News CoverageAnalyst RevisionGap Down1.18%EWTXEdgewise Therapeutics$15.29-0.8%2.6529 of 5 stars2.78$39.78 160.2%9Gap Up1.15%CLDXCelldex Therapeutics$21.26+4.5%2.6411 of 5 stars2.90$50.90 139.4%10Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.11%MNKDMannKind$3.71-3.1%3.0769 of 5 stars3.29$10.33 178.5%7Analyst UpgradeInsider TradeAnalyst Revision1.09%LQDALiquidia$14.10-2.4%3.6927 of 5 stars3.00$26.89 90.7%9Analyst ForecastOptions Volume1.08%VERAVera Therapeutics$22.74+1.0%2.8835 of 5 stars3.10$65.00 185.8%10Short Interest ↑Analyst RevisionGap Up1.02%VRDNViridian Therapeutics$15.88+1.3%1.7889 of 5 stars2.90$37.56 136.5%10Positive NewsGap Down0.98%AUPHAurinia Pharmaceuticals$8.18-0.6%3.2745 of 5 stars3.00$11.50 40.6%2Positive NewsAnalyst Revision0.97%NVAXNovavax$6.94-2.9%3.8571 of 5 stars2.50$19.20 176.7%6Gap Down0.92%NTLAIntellia Therapeutics$8.31-0.5%4.6564 of 5 stars2.67$34.95 320.6%21Positive NewsAnalyst RevisionGap Down0.87%RCUSArcus Biosciences$9.25-1.1%2.2661 of 5 stars2.90$24.13 160.8%10Options VolumeAnalyst RevisionGap Up0.70%PHVSPharvaris$16.70-3.1%1.3979 of 5 stars3.00$36.20 116.8%5Analyst ForecastAnalyst Revision0.68%PRAXPraxis Precision Medicines$44.30-1.6%2.7652 of 5 stars2.80$109.90 148.1%10Positive NewsAnalyst Forecast0.68%MLYSMineralys Therapeutics$14.32-4.0%2.7488 of 5 stars2.75$32.25 125.2%4Analyst ForecastGap Down0.67%NUVBNuvation Bio$1.73-4.7%2.95 of 5 stars3.17$7.83 354.1%6News CoverageAnalyst ForecastHigh Trading Volume0.66%IMNMImmunome$9.20-6.0%1.6186 of 5 stars3.00$23.33 153.6%6News CoveragePositive NewsGap Down0.62%AVBPArriVent BioPharma$23.27-1.5%1.4643 of 5 stars3.14$39.29 68.8%7Positive NewsHigh Trading Volume0.60%VIRVir Biotechnology$5.222.9889 of 5 stars2.86$32.86 529.4%7Positive NewsGap Down0.60%ANABAnaptysBio$23.32-0.4%1.6228 of 5 stars2.80$42.38 81.7%10Positive News0.58%REPLReplimune Group$9.78-1.1%4.5172 of 5 stars3.14$20.83 113.0%7Positive NewsGap Down0.58%FLGTFulgent Genetics$20.69-1.4%3.7475 of 5 stars2.50$24.00 16.0%2Gap Down0.57%DAWNDay One Biopharmaceuticals$6.67-0.3%1.4711 of 5 stars3.13$30.57 358.3%80.56%AVXLAnavex Life Sciences$8.03-2.3%3.8503 of 5 stars3.33$44.00 447.9%3Positive NewsGap Down0.54%KROSKeros Therapeutics$13.56-0.6%3.6179 of 5 stars2.50$30.56 125.3%14Analyst DowngradeGap Down0.52%DNTHDianthus Therapeutics$18.31-5.1%1.371 of 5 stars3.13$53.00 189.5%8Analyst Revision0.48%XNCRXencor$9.19-2.5%4.1173 of 5 stars2.75$28.00 204.7%8Positive NewsGap Down0.46%STOKStoke Therapeutics$11.53-2.5%3.644 of 5 stars3.29$23.20 101.2%7Analyst Revision0.44%UPBUpstream Bio$11.36-1.7%1.749 of 5 stars3.00$56.50 397.4%4Gap Down0.44%CAPRCapricor Therapeutics$11.78-15.5%2.2546 of 5 stars3.00$35.50 201.4%6Analyst ForecastOptions VolumeAnalyst RevisionGap Down0.41%AUTLAutolus Therapeutics$2.12-1.4%2.5609 of 5 stars3.00$9.32 339.6%5News CoveragePositive NewsAnalyst ForecastGap Up0.41%TBPHTheravance Biopharma$10.69+0.8%0.8648 of 5 stars2.25$11.33 6.0%4Positive News0.40%MBXMBX Biosciences$10.37-3.3%2.0119 of 5 stars3.00$37.50 261.6%6Gap Up0.40%AMLXAmylyx Pharmaceuticals$5.524.1366 of 5 stars3.11$9.83 78.1%9Analyst DowngradeGap Down0.37%CELCCelcuity$12.11-3.6%1.9071 of 5 stars3.17$30.80 154.3%6Positive News0.35%ITOSiTeos Therapeutics$10.17+1.9%3.739 of 5 stars2.14$15.86 55.9%7Insider Trade0.34%CMPSCOMPASS Pathways$4.39-2.9%2.4964 of 5 stars3.00$18.83 329.0%6Positive NewsGap Down0.34%TRMLTourmaline Bio$19.68-1.1%2.84 of 5 stars3.00$49.33 150.7%7Positive NewsAnalyst RevisionGap Down0.32%ZBIOZenas Biopharma$10.33-8.7%1.2735 of 5 stars3.00$36.67 255.0%3Trending NewsGap Up0.31%OLMAOlema Pharmaceuticals$4.17+2.7%2.5271 of 5 stars3.00$24.50 487.5%4Positive NewsGap Down0.31%RAPPRapport Therapeutics$11.19+0.4%1.9513 of 5 stars3.00$32.67 191.9%4Positive News0.31%RIGLRigel Pharmaceuticals$20.52-3.7%3.274 of 5 stars2.40$36.40 77.4%5Positive NewsAnalyst Revision0.30%SVRASavara$2.21-2.2%2.0549 of 5 stars2.67$7.17 224.3%6Gap Down0.29%ARCTArcturus Therapeutics$12.38-2.1%3.2096 of 5 stars3.11$53.50 332.1%9Positive NewsAnalyst RevisionGap Down0.28%ERASErasca$1.48-3.3%2.7303 of 5 stars3.00$4.57 208.9%7Positive NewsGap Down0.27%AURAAura Biosciences$6.42-3.7%2.5174 of 5 stars3.25$22.00 242.7%8Positive News0.23%ATXSAstria Therapeutics$5.72+2.1%2.3456 of 5 stars3.25$30.00 424.5%8News CoverageAnalyst ForecastAnalyst RevisionGap Down0.22%VNDAVanda Pharmaceuticals$4.51-2.6%4.6151 of 5 stars3.50$16.50 265.9%2News CoverageAnalyst UpgradeAnalyst Revision0.22%RNACCartesian Therapeutics$10.42+1.8%1.8707 of 5 stars2.71$43.00 312.7%7Positive NewsAnalyst RevisionGap Down0.21%PRTAProthena$5.08+0.2%3.9152 of 5 stars2.33$31.50 520.1%9Positive NewsShort Interest ↓Analyst Revision0.21%ANNXAnnexon$2.49-8.1%2.2196 of 5 stars3.00$12.50 402.0%3Positive NewsAnalyst Revision0.21%RZLTRezolute$4.20-4.5%2.6631 of 5 stars3.14$11.83 181.7%7Positive News0.19%YMABY-mAbs Therapeutics$4.71+1.7%3.5437 of 5 stars2.82$15.60 231.2%11Analyst Revision0.17%CRGXCARGO Therapeutics$4.39-2.0%2.3796 of 5 stars1.86$15.00 241.7%7Positive News0.17%ELDNEledon Pharmaceuticals$2.87-4.3%2.846 of 5 stars3.00$12.50 335.5%20.16%URGNUroGen Pharma$12.03+8.6%4.6713 of 5 stars2.88$28.71 138.7%8Trending NewsAnalyst ForecastShort Interest ↓Gap UpHigh Trading Volume0.14%FDMT4D Molecular Therapeutics$4.39-2.4%2.8651 of 5 stars2.60$29.56 573.2%10Positive NewsAnalyst ForecastAnalyst Revision0.14%ACRSAclaris Therapeutics$1.47-3.9%2.6658 of 5 stars3.11$9.71 560.8%9Positive News0.13%ALECAlector$1.54-4.9%3.3478 of 5 stars2.14$4.00 159.7%7News CoverageShort Interest ↑Analyst Revision0.12%ALDXAldeyra Therapeutics$2.78-5.1%2.8484 of 5 stars3.00$9.50 241.7%2Positive NewsGap Down0.12%ENTAEnanta Pharmaceuticals$7.50+1.2%3.7014 of 5 stars2.80$18.00 140.0%5Analyst DowngradeGap Down0.12%LRMRLarimar Therapeutics$2.88-1.0%2.525 of 5 stars3.11$19.67 582.9%9Short Interest ↓Gap Down0.10%NMRANeumora Therapeutics$0.84-6.2%1.9436 of 5 stars2.22$9.29 999.6%9Gap Down0.10%KYTXKyverna Therapeutics$3.22-6.9%2.4772 of 5 stars3.14$18.50 474.5%70.09%IRWDIronwood Pharmaceuticals$0.62-7.2%4.6559 of 5 stars2.13$4.78 671.5%8Positive NewsGap Down0.08%PROKProKidney$0.84-6.4%2.4201 of 5 stars2.33$4.50 436.8%3Positive News0.08%PLRXPliant Therapeutics$1.38-6.1%4.3009 of 5 stars2.00$13.31 864.7%12Positive NewsAnalyst RevisionGap Down0.08%MGNXMacroGenics$1.52-1.9%3.7641 of 5 stars2.40$5.71 275.9%10Options VolumeGap Down0.08%ZNTLZentalis Pharmaceuticals$1.34-8.2%2.312 of 5 stars2.44$8.24 515.3%9Positive NewsGap Down0.07%STROSutro Biopharma$0.80-1.5%4.2162 of 5 stars2.13$6.11 665.1%8Positive News This page (NYSEARCA:SBIO) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.